Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
30.38
-3.56 (-10.49%)
At close: May 8, 2026, 4:00 PM EDT
30.20
-0.18 (-0.59%)
After-hours: May 8, 2026, 7:40 PM EDT
Capricor Therapeutics Market Cap
Capricor Therapeutics has a market cap or net worth of $1.76 billion as of May 8, 2026. Its market cap has increased by 189.68% in one year.
Market Cap
1.76B
Enterprise Value
1.45B
1-Year Change
189.68%
Ranking
Category
Stock Price
$30.38
Market Cap Chart
Since May 13, 2008, Capricor Therapeutics's market cap has increased from $130.10M to $1.76B, an increase of 1,250.64%. That is a compound annual growth rate of 15.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.75B | 32.42% |
| Dec 31, 2025 | 1.32B | 110.26% |
| Dec 31, 2024 | 627.50M | 316.67% |
| Dec 29, 2023 | 150.60M | 54.62% |
| Dec 30, 2022 | 97.40M | 37.57% |
| Dec 31, 2021 | 70.80M | 1.00% |
| Dec 31, 2020 | 70.10M | 1,198.15% |
| Dec 31, 2019 | 5.40M | -57.48% |
| Dec 31, 2018 | 12.70M | -68.72% |
| Dec 29, 2017 | 40.60M | -28.65% |
| Dec 30, 2016 | 56.90M | 13.80% |
| Dec 31, 2015 | 50.00M | 13.90% |
| Dec 31, 2014 | 43.90M | 1,467.86% |
| Dec 31, 2013 | 2.80M | 27.27% |
| Dec 31, 2012 | 2.20M | -89.91% |
| Dec 30, 2011 | 21.80M | 1.40% |
| Dec 31, 2010 | 21.50M | -36.39% |
| Dec 31, 2009 | 33.80M | 38.52% |
| Dec 31, 2008 | 24.40M | -81.25% |
| May 13, 2008 | 130.10M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.79B |
| Ardelyx | 1.76B |
| Recursion Pharmaceuticals | 1.71B |
| Viridian Therapeutics | 1.70B |
| Innoviva | 1.70B |
| Nurix Therapeutics | 1.68B |
| Novavax | 1.68B |
| Monte Rosa Therapeutics | 1.68B |